Tricyclic HIV integrase inhibitors: Potent and orally bioavailable C5-aza analogs

被引：19

作者：

Jin, Haolun ^{[1
]}

Wright, Matthew ^{[1
]}

Pastor, Richard ^{[1
]}

Mish, Michael ^{[1
]}

Metobo, Sammy ^{[1
]}

Jabri, Salman ^{[1
]}

Lansdown, Rachael ^{[1
]}

Cai, Ruby ^{[1
]}

Pyun, Peter ^{[1
]}

Tsiang, Manuel ^{[1
]}

Chen, Xiaowu ^{[1
]}

Kim, Choung U. ^{[1
]}

机构：

[1] Gilead Sci Inc, Dept Med Chem, Foster City, CA 94404 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2008年 / 18卷 / 04期

关键词：

D O I：

10.1016/j.bmcl.2008.01.018

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of C5-aza tricyclic HIV integrase inhibitors was prepared. A highly potent and orally bioavailable compound ( compound 9) was identified and selected for development. (c) 2008 Elsevier Ltd. All rights reserved.

引用

页码：1388 / 1391

页数：4

共 50 条

[1] Design and synthesis of bicyclic pyrimidinones as potent and orally bioavailable HIV-1 integrase inhibitors
Muraglia, Ester
Kinzel, Olaf
Gardelli, Cristina
Crescenzi, Benedetta
Donghi, Monica
Ferrara, Marco
Nizi, Emanuela
Orvieto, Federica
Pescatore, Giovanna
Laufer, Ralph
Gonzalez-Paz, Odalys
Di Marco, Annalise
Fiore, Fabrizio
Monteagudo, Edith
Fonsi, Massimiliano
Felock, Peter J.
Rowley, Michael
Summa, Vincenzo
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (04) : 861 - 874
[2] Discovery of Potent, Orally Bioavailable, Tricyclic NLRP3 Inhibitors
Velcicky, Juraj
Janser, Philipp
Gommermann, Nina
Brenneisen, Silke
Ilic, Slavica
Vangrevelinghe, Eric
Stiefl, Nikolaus
Boettcher, Andreas
Arnold, Christelle
Malinverni, Claire
Dawson, Janet
Murgasova, Renata
Desrayaud, Sandrine
Beltz, Karen
Hinniger, Alexandra
Dekker, Carien
Farady, Christopher J.
Mackay, Angela
JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (02) : 1544 - 1562
[3] Discovery and Optimization of Novel Pyrazolopyrimidines as Potent and Orally Bioavailable Allosteric HIV-1 Integrase Inhibitors
Li, Guo
Meanwell, Nicholas A.
Krystal, Mark R.
Langley, David R.
Naidu, B. Narasimhulu
Sivaprakasam, Prasanna
Lewis, Hal
Kish, Kevin
Khan, Javed A.
Ng, Alicia
Trainor, George L.
Cianci, Christopher
Dicker, Ira B.
Walker, Michael A.
Lin, Zeyu
Protack, Tricia
Discotto, Linda
Jenkins, Susan
Gerritz, Samuel W.
Pendri, Annapurna
JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (05) : 2620 - 2637
[4] Discovery and synthesis of HIV integrase inhibitors: Development of potent and orally bioavailable N-methyl Pyrimidones
Gardelli, Cristina
Nizi, Emanuela
Muraglia, Ester
Crescenzi, Benedetta
Ferrara, Marco
Orvieto, Federica
Pace, Paola
Pescatore, Giovanna
Poma, Marco
Ferreira, Maria del Rosario Rico
Scarpelli, Rita
Homnick, Carl F.
Ikemoto, Norihiro
Alfieri, Anna
Verdirame, Maria
Bonelli, Fabio
Paz, Odalys Gonzalez
Taliani, Marina
Monteagudo, Edith
Pesci, Silvia
Laufer, Ralph
Felock, Peter
Stillmock, Kara A.
Hazuda, Daria
Rowley, Michael
Summa, Vincenzo
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (20) : 4953 - 4975
[5] Development of 2-pyrrolidinyl-N-methyl pyrimidones as potent and orally bioavailable HIV integrase inhibitors
Ferrara, Marco
Fiore, Fabrizio
Summa, Vincenzo
Gardelli, Cristina
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (17) : 5031 - 5034
[6] C7-Heteroaryl-indoles as potent and orally bioavailable inhibitors of HIV attachment
Yeung, Kap-Sun
Qiu, Zhilei
Fang, Haiquan
Yin, Zhiwei
Farkas, Michelle E.
Trehan, Ashok
Pearce, Bradley
Wright, J. J. Kim
Ricandi, Keith
Spicer, Timothy P.
Shi, Pei-Yong
Gong, Yi-Fei
Colonno, Richard J.
Yang, Zheng
Zadjura, Lisa
D'Arienzo, Celia J.
Browning, Marc R.
Hansel, Steven
Santone, Kenneth
Barker, Jonathan
Taylor, Malcolm
Coxhead, Richard
Thomas, Russell
Coulter, Thomas
Lin, Ping-Fan
Meanwell, Nicholas A.
Kadow, John F.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
[7] Design and Synthesis of Novel N-Hydroxy-Dihydronaphthyridinones as Potent and Orally Bioavailable HIV-1 Integrase Inhibitors
Johnson, Ted W.
Tanis, Steven P.
Butler, Scott L.
Dalvie, Deepak
DeLisle, Dorothy M.
Dress, Klaus R.
Flahive, Erik J.
Hu, Qiyue
Kuehler, Jon E.
Kuki, Atsuo
Liu, Wen
McClellan, Guy A.
Peng, Qinghai
Plewe, Michael B.
Richardson, Paul F.
Smith, Graham L.
Solowiej, Jim
Tran, Khanh T.
Wang, Hai
Yu, Xiaoming
Zhang, Junhu
Zhu, Huichun
JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (09) : 3393 - 3417
[8] The identification of potent, orally bioavailable tricyclic CGRP receptor antagonists
Bell, Ian M.
Bednar, Rodney A.
Corcoran, Halea A.
Fay, John F.
Gallicchio, Steven N.
Johnston, Victor K.
Hershey, James C.
Miller-Stein, Cynthia M.
Moore, Eric L.
Mosser, Scott D.
Roller, Shane A.
Salvatore, Christopher A.
Theberge, Cory R.
Wong, Bradley K.
Zartman, C. Blair
Kane, Stefanie A.
Williams, Theresa M.
Graham, Samuel L.
Vacca, Joseph P.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (16) : 4740 - 4742
[9] DESIGN AND SYNTHESIS OF POTENT, ORALLY BIOAVAILABLE HIV-1 PROTEASE INHIBITORS
KALDOR, SW
KALISH, V
DRESSMAN, BA
FRITZ, JE
HAMMOND, M
CROWELL, TA
TATLOCK, J
REICH, S
DAVIES, J
APPELT, K
SHETTY, B
SU, KS
CAMPANALE, KM
BURGESS, JA
LUBBENHUSEN, PP
BAXTER, AJ
MUESING, MA
HATCH, SD
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 208 : 17 - MEDI
[10] Discovery of Raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infection
Summa, Vincenzo
Petrocchi, Alessia
Bonelli, Fabio
Crescenzi, Benedetta
Donghi, Monica
Ferrara, Marco
Fiore, Fabrizio
Gardelli, Cristina
Paz, Odalys Gonzalez
Hazuda, Daria J.
Jones, Philip
Kinzel, Olaf
Laufer, Ralph
Monteagudo, Edith
Muraglia, Ester
Nizi, Emanuela
Orvieto, Federica
Pace, Paola
Pescatore, Giovanna
Scarpelli, Rita
Stillmock, Kara
Witmer, Marc V.
Rowley, Michael
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (18) : 5843 - 5855

← 1 2 3 4 5 →